This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n11http://linked.opendata.cz/resource/drugbank/drug/DB07131/identifier/pdb/
n4http://linked.opendata.cz/resource/drugbank/drug/DB07131/identifier/pubchem-compound/
n9http://bio2rdf.org/drugbank:
n7http://linked.opendata.cz/resource/drugbank/drug/DB07131/identifier/pubchem-substance/
n10http://linked.opendata.cz/resource/drugbank/drug/DB07131/identifier/drugbank/
admshttp://www.w3.org/ns/adms#
n12http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n5http://linked.opendata.cz/ontology/drugbank/
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB07131
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n9:DB07131 n12:DB07131
dcterms:title
(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclohexylpropanoyl)pyrrolidine-2-carboxamide
adms:identifier
n4:25134248 n7:99443602 n10:DB07131 n11:50U
n5:IUPAC-Name
n6:271B4CF3-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B4CF9-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B4CF8-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B4CF5-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B4CF6-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B4CF7-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B4CF1-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B4CEF-363D-11E5-9242-09173F13E4C5 n6:271B4CF2-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B4CF0-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B4CFF-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B4D00-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B4CFA-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B4CFB-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B4CFD-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B4CFC-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B4CFE-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B4D05-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B4D07-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B4D08-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B4D04-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B4D03-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B4D06-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B4CF4-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B4D01-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B4D02-363D-11E5-9242-09173F13E4C5